Floatz logo

Sodium Thiosulfate

HIPEC

National Cancer Center, KoreaSmall moleculePhase 3Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the HIPEC cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Center, Korea
Phase 3B
Ici-Hipet
Jing Li
Phase 2CCC
Raltitrexed
Fudan University
Phase 1CC

Same molecule, other indications

Sodium Thiosulfate is also rated in:

central nervous system neoplasmDormant
BB
Indicative ·
70 / 100
View asset →
sarcomaDormant
BB
Indicative ·
65 / 100
View asset →
Epithelial Ovarian CancerDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →